Saint Bernards Medical Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Pancreatic cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Amgen2 trials
• Gilead Sciences1 trial

Running trials

• Active, not recruiting

  A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

  NCT07005128· Phase 3· Amgen· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382286· Phase 3· Gilead Sciences· Source

Closed trials

• Completed

  Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

  NCT03362177· Phase 3· Amgen· Source